相似文献
1
Bioavailability and dissolution of proprietary and generic formulations of phenytoin.
J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):688-91. doi: 10.1136/jnnp.55.8.688.
2
Bioavailability of phenytoin. A comparison of two preparations.
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):209-12. doi: 10.1007/BF00614019.
3
[Evaluation of the bioavailability of Polfa phenytoin tablets].
Neurol Neurochir Pol. 1978 May-Jun;12(3):251-5.
4
Comparative bioavailability of phenytoin from generic formulations in the United Kingdom.
Epilepsia. 1982 Apr;23(2):149-52. doi: 10.1111/j.1528-1157.1982.tb05062.x.
5
Comparison of the effectiveness of two oral phenytoin products and chronopharmacokinetics of phenytoin.
J Clin Pharm Ther. 1993 Jun;18(3):213-7. doi: 10.1111/j.1365-2710.1993.tb00616.x.
6
Comparison of serum phenytoin levels in epileptic patients who swallowed their phenytoin tablets with or without previous chewing.
Eur J Clin Pharmacol. 1978 Nov 27;14(3):191-4. doi: 10.1007/BF02089959.
7
Plasma level studies on different brands of sodium diphenylhydantoin (DPH) and primidone.
Int J Clin Pharmacol Biopharm. 1975 Oct;12(3):309-14.
8
Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy.
J Pharm Pharmacol. 1991 Feb;43(2):117-9. doi: 10.1111/j.2042-7158.1991.tb06644.x.
9
Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.
Br J Clin Pharmacol. 1979 Jul;8(1):37-41. doi: 10.1111/j.1365-2125.1979.tb05906.x.
10
A comparative bioavailability of 2 oral solid phenytoin dosage forms.
Cent Afr J Med. 1989 Apr;35(4):384-8.
引用本文的文献
1
Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug-Drug Interactions of Phenytoin.
Pharmaceutics. 2023 Oct 18;15(10):2486. doi: 10.3390/pharmaceutics15102486.
2
Therapeutic Basis of Generic Substitution of Antiseizure Medications.
J Pharmacol Exp Ther. 2022 May;381(2):188-196. doi: 10.1124/jpet.121.000994. Epub 2022 Mar 3.
3
Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products.
AAPS J. 2021 Apr 21;23(3):57. doi: 10.1208/s12248-021-00592-y.
4
Potential problems and recommendations regarding substitution of generic antiepileptic drugs: a systematic review of literature.
Springerplus. 2016 Feb 25;5:182. doi: 10.1186/s40064-016-1824-2. eCollection 2016.
5
Three-way, three-period, crossover bioequivalence study of single oral dose of three brands of 300 mg phenytoin sodium tablets marketed in India, on healthy Indian human volunteers.
J Pharmacol Pharmacother. 2013 Oct;4(4):243-6. doi: 10.4103/0976-500X.119709.
6
Impact of generic substitution of anticonvulsants on the treatment of epilepsy.
CNS Drugs. 1997 Aug;8(2):124-33. doi: 10.2165/00023210-199708020-00004.
7
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.
Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000.
8
Substitution of anticonvulsant drugs.
Ther Clin Risk Manag. 2009 Jun;5(3):449-57. doi: 10.2147/tcrm.s5366. Epub 2009 Jun 22.
9
Prescribing antiepileptic drugs: should patients be switched on the basis of cost?
CNS Drugs. 2004;18(10):617-28. doi: 10.2165/00023210-200418100-00001.
10
Is generic prescribing acceptable in epilepsy?
Drug Saf. 2000 Sep;23(3):173-82. doi: 10.2165/00002018-200023030-00001.
本文引用的文献
1
Comparative bioavailability of phenytoin from generic formulations in the United Kingdom.
Epilepsia. 1982 Apr;23(2):149-52. doi: 10.1111/j.1528-1157.1982.tb05062.x.
2
Outbreak of anticonvulsant intoxication in an Australian city.
Br Med J. 1970 Oct 31;4(5730):271-3. doi: 10.1136/bmj.4.5730.271.
3
Factors involved in an outbreak of phenytoin intoxication.
J Neurol Sci. 1972 Aug;16(4):481-7. doi: 10.1016/0022-510x(72)90053-6.
4
Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin.
Eur J Clin Pharmacol. 1974;7(2):119-24. doi: 10.1007/BF00561325.
5
Blood phenytoin concentrations produced by ingestion of three different phenytoin preparations.
Med J Aust. 1972 Feb 26;1(9):410-1. doi: 10.5694/j.1326-5377.1972.tb106535.x.
6
Bio-availability and dissolution of three phenytoin preparations for children.
Dev Med Child Neurol. 1986 Dec;28(6):708-12. doi: 10.1111/j.1469-8749.1986.tb03921.x.
7
A comparative study of the bioavailability of five different phenytoin preparations.
J Pharm Pharmacol. 1985 Aug;37(8):570-2. doi: 10.1111/j.2042-7158.1985.tb03070.x.
8
Generic substitutions for antiepileptic drugs.
Neurology. 1990 Nov;40(11):1647-51. doi: 10.1212/wnl.40.11.1647.
9
Phenytoin: pharmacokinetics and bioavailability.
Clin Pharmacol Ther. 1976 Feb;19(2):135-42. doi: 10.1002/cpt1976192135.
10
Bioavailability of four brands of phenytoin tablets.
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):213-8. doi: 10.1007/BF00614020.
Zotero 插件